Wonbiogen

307280 · KOSDAQ · ₩307280 · 원바이오젠

₩5,500▼ ₩120 (2.14%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩35B₩30B₩30B₩27B₩18B
Cost of sales₩17B₩16B₩15B₩14B₩10B
Gross profit₩18B₩14B₩14B₩12B₩7.6B
Operating income₩7.9B₩6.4B₩7.1B₩5.2B₩2B
Net income₩6.5B₩5.3B₩6B₩3.3B−₩660M
Net income to shareholders₩6.6B₩5.7B₩5.5B₩3.3B−₩660M

Balance sheet

20252024202320222021
Total assets₩48B₩41B₩43B₩39B₩38B
Current assets₩27B₩22B₩21B₩18B₩23B
Cash and equivalents₩8.3B₩7.2B₩3B₩3.2B₩7.7B
Total liabilities₩5B₩4B₩10B₩12B₩11B
Current liabilities₩4.5B₩3.3B₩9.3B₩12B₩11B
Borrowings₩367M₩617M₩6.8B₩758M₩831M
Total equity₩43B₩37B₩33B₩27B₩27B
Shareholders' equity₩43B₩37B₩32B₩27B₩27B

Cash flow

20252024202320222021
Cash from operations₩8.5B₩8.8B₩4.8B₩5.8B₩1.1B
Capital spending₩2B₩648M₩1.6B₩6.5B₩2.3B
Free cash flow₩6.5B₩8.2B₩3.2B−₩712M−₩1.3B
Dividends paid₩709M₩709M₩350M——

Consolidated where available. Amounts in won.

Also known as: Wonbiogen / 원바이오젠 / 307280 / KRX:307280

Source: KRX statistical information